Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels.
- DOI
- 10.1016/j.ebiom.2023.104692
- Published
- 2023 Aug
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2023.104692,
title = {Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels.},
author = {Murray A and Gough G and Cindrić A and Vučković F and Koschut D and Borelli V and Petrović DJ and Bekavac A and Plećaš A and Hribljan V and Brunmeir R and Jurić J and Pučić-Baković M and Slana A and Deriš H and Frkatović A and Groet J and O'Brien NL and Chen HY and Yeap YJ and Delom F and Havlicek S and Gammon L and Hamburg S and Startin C and D'Souza H and Mitrečić D and Kero M and Odak L and Krušlin B and Krsnik Ž and Kostović I and Foo JN and Loh YH and Dunn NR and de la Luna S and Spector T and Barišić I and Thomas MSC and Strydom A and Franceschi C and Lauc G and Krištić J and Alić I and Nižetić D},
year = {2023},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2023.104692},
url = {https://doi.org/10.1016/j.ebiom.2023.104692}
}RIS
TY - JOUR TI - Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels. AU - Murray A AU - Gough G AU - Cindrić A AU - Vučković F AU - Koschut D AU - Borelli V AU - Petrović DJ AU - Bekavac A AU - Plećaš A AU - Hribljan V AU - Brunmeir R AU - Jurić J AU - Pučić-Baković M AU - Slana A AU - Deriš H AU - Frkatović A AU - Groet J AU - O'Brien NL AU - Chen HY AU - Yeap YJ AU - Delom F AU - Havlicek S AU - Gammon L AU - Hamburg S AU - Startin C AU - D'Souza H AU - Mitrečić D AU - Kero M AU - Odak L AU - Krušlin B AU - Krsnik Ž AU - Kostović I AU - Foo JN AU - Loh YH AU - Dunn NR AU - de la Luna S AU - Spector T AU - Barišić I AU - Thomas MSC AU - Strydom A AU - Franceschi C AU - Lauc G AU - Krištić J AU - Alić I AU - Nižetić D PY - 2023 JO - EBioMedicine DO - 10.1016/j.ebiom.2023.104692 UR - https://doi.org/10.1016/j.ebiom.2023.104692 ER -
APA
A, M., G, G., A, C., F, V., D, K., V, B., DJ, P., A, B., A, P., V, H., R, B., J, J., M, P., A, S., H, D., A, F., J, G., NL, O., HY, C., YJ, Y., F, D., S, H., L, G., S, H., C, S., H, D., D, M., M, K., L, O., B, K., Ž, K., I, K., JN, F., YH, L., NR, D., S, D. L. L., T, S., I, B., MSC, T., A, S., C, F., G, L., J, K., I, A., & D, N. (2023). Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2023.104692
Source records
- pubmed · retrieved 2026-09-26T16:43:46.527Z